Td Asset Management Inc Dexcom Inc Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

A detailed history of Td Asset Management Inc transactions in Dexcom Inc stock. As of the latest transaction made, Td Asset Management Inc holds 230,680 shares of DXCM stock, worth $18.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

230,680

Previous 276,948 16.71%

Holding current value

$18.5 Million

Previous $31.4 Million 50.76%

% of portfolio

0.01%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$64.0 - $116.06 $2.96 Million - $5.37 Million	-46,268 Reduced 16.71%	230,680 $15.5 Million
Q2 2024 Aug 02, 2024	SELL	$110.31 - $140.45 $672,449 - $856,183	-6,096 Reduced 2.15%	276,948 $31.4 Million
Q1 2024 May 08, 2024	SELL	$114.22 - $140.1 $1.7 Million - $2.08 Million	-14,875 Reduced 4.99%	283,044 $39.3 Million
Q4 2023 Feb 12, 2024	BUY	$75.49 - $124.16 $1.57 Million - $2.58 Million	20,757 Added 7.49%	297,919 $37 Million
Q3 2023 Oct 27, 2023	BUY	$86.06 - $137.93 $4.12 Million - $6.6 Million	47,876 Added 20.88%	277,162 $25.9 Million
Q2 2023 Aug 09, 2023	SELL	$112.47 - $130.98 $1.98 Million - $2.31 Million	-17,645 Reduced 7.15%	229,286 $29.5 Million
Q1 2023 May 10, 2023	BUY	$104.0 - $122.92 $129,064 - $152,543	1,241 Added 0.51%	246,931 $28.7 Million
Q4 2022 Feb 06, 2023	BUY	$84.98 - $122.67 $293,435 - $423,579	3,453 Added 1.43%	245,690 $27.8 Million
Q3 2022 Nov 07, 2022	SELL	$76.35 - $94.18 $17,484 - $21,567	-229 Reduced 0.09%	242,237 $19.9 Million
Q2 2022 Aug 04, 2022	BUY	$67.99 - $132.89 $12.3 Million - $24.1 Million	181,349 Added 296.72%	242,466 $18.1 Million
Q1 2022 May 10, 2022	SELL	$94.08 - $130.2 $9,219 - $12,759	-98 Reduced 0.16%	61,117 $31.3 Million
Q4 2021 Feb 10, 2022	SELL	$129.87 - $162.82 $259,220 - $324,988	-1,996 Reduced 3.16%	61,215 $32.9 Million
Q3 2021 Nov 09, 2021	SELL	$106.71 - $143.18 $95,612 - $128,289	-896 Reduced 1.4%	63,211 $34.6 Million
Q2 2021 Aug 11, 2021	BUY	$80.99 - $107.93 $43,653 - $58,174	539 Added 0.85%	64,107 $33 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $461,681 - $570,309	-5,445 Reduced 7.89%	63,568 $22.8 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $360,750 - $483,312	4,625 Added 7.18%	69,013 $25.5 Million
Q3 2020 Nov 10, 2020	BUY	$95.51 - $112.95 $1.05 Million - $1.24 Million	10,991 Added 20.58%	64,388 $26.5 Million
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $1.15 Million - $1.93 Million	18,369 Added 52.44%	53,397 $21.6 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $224,613 - $355,461	-4,700 Reduced 11.83%	35,028 $9.43 Million
Q4 2019 Feb 11, 2020	SELL	$36.62 - $57.29 $166,328 - $260,211	-4,542 Reduced 10.26%	39,728 $8.69 Million
Q3 2019 Nov 07, 2019	BUY	$35.53 - $43.8 $62,177 - $76,650	1,750 Added 4.12%	44,270 $6.61 Million
Q2 2019 Aug 01, 2019	BUY	$27.84 - $38.92 $429,960 - $601,080	15,444 Added 57.04%	42,520 $6.37 Million
Q1 2019 May 08, 2019	BUY	$28.07 - $38.18 $410,074 - $557,771	14,609 Added 117.18%	27,076 $3.23 Million
Q4 2018 Feb 01, 2019	SELL	$26.99 - $37.37 $1.59 Million - $2.2 Million	-58,806 Reduced 82.51%	12,467 $1.49 Million
Q3 2018 Nov 01, 2018	SELL	$23.35 - $36.72 $191,470 - $301,104	-8,200 Reduced 10.32%	71,273 $10.2 Million
Q2 2018 Jul 31, 2018	SELL	$17.54 - $25.22 $611,111 - $878,690	-34,841 Reduced 30.48%	79,473 $7.55 Million
Q1 2018 May 11, 2018	BUY	$13.06 - $18.54 $37,874 - $53,766	2,900 Added 2.6%	114,314 $8.48 Million
Q4 2017 Feb 02, 2018	BUY	$11.12 - $15.38 $835,779 - $1.16 Million	75,160 Added 207.32%	111,414 $6.39 Million
Q3 2017 Nov 09, 2017	BUY	$11.36 - $18.98 $411,845 - $688,100	36,254	36,254 $1.77 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Dexcom Inc Transaction History